As you may have heard that Liquid biopsy has become an attractive tool for a range of clinical applications, including early cancer detection. Scientists investigates, “liquid biopsy shows earlier detection of cancer in patients with LFS compared with current clinical surveillance methods such as imaging”, by utilizing an integrated cell-free DNA approach. Liquid biopsy provides improved accessibility and sensitivity, complementing current clinical surveillance methods to provide better care for these patients.